RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
This #tweetorial was composed from the following references (4/4): Fu, B., et al. Why tocilizumab could be an effective treatment for severe COVID-19?. J Transl Med 18, 164 (2020). https://t.co/uS4vocB8Ns
April 2020- preliminary report for Actemra https://t.co/1iLz0YmP5P https://t.co/8SYMz63V9D
RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
Tocilizumab is an effective treatment in severe patients of COVID-19 to calm the inflammatory storm and reduce mortality. https://t.co/OiFHj9Hw7w
@Potlaakarilehti *https://t.co/PjDi6fnRX3 RoActemra on saanut myyntiluvan EU:ssa vuonna 2009. *https://t.co/u0kjs9zctg Future Med Chem. 2009 Oct; 1(7): 1333–1349. doi: 10.4155/fmc.09.93 Pohtikaa hetki päissänne miksi.
RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
RT @CetiCov: tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relative…
tocilizumab certains espoirs thérapeutiques ont été placé dans cet inhibiteur monoclonal de l’IL6 avec des résultats relativement encourageants quant au potentiel thérapeutique https://t.co/u4G5fQs3mz https://t.co/WkLX9K0LmR https://t.co/onSwV16qq5
RT @DrLBoominathan: What is tocilizumab? Why is it important for the treatment of cytokine storm in COVID-19 patients? https://t.co/zxAWwHq…
What is tocilizumab? Why is it important for the treatment of cytokine storm in COVID-19 patients? https://t.co/zxAWwHqWJ6 To gain mechanistic insights and to know therapeutic options available for COVID-19: https://t.co/6ySOYUZ1l5 https://t.co/ZGNRi4kPDo
3-16-2020: The 2 Chinese pro-Actemra meta-analyses (Jie Zhao, Meng Zhao) & 5 Chinese pro-Actemra studies (Pan Luo, Jianbo Tian, Xiaoling Xu, Jia Zeng, Kai-Lian Zheng). Now, the first Actemra study of the pandemic by Binqing Fu is China's 6th, world's 7
What is tolizumab? https://t.co/njtaLGq1Vz "Tocilizumab calms the inflammatory storm through blocking IL-6 receptors" https://t.co/CO5KKoEi1r
Pòssibley good, if eexhausting,news...https://t.co/h1FM9jzwaP
RT @DrChavezDiaz: #tocilizumab bloquea los receptores de IL-6, incluida disminución de la fiebre y mejoró la función respiratoria. Podría…
#tocilizumab bloquea los receptores de IL-6, incluida disminución de la fiebre y mejoró la función respiratoria. Podría ser efectivo en pacientes graves con COVID-19 para calmar la tormenta inflamatoria y reducir la mortalidad https://t.co/mz9M18LODZ
interesting... #COVID__19 #coronavirus https://t.co/DxvYPyN5cC
Tocilizumab promising. https://t.co/5E3pKTG2Go
@b747jet 可能性はある、証拠はまだ足りないっというべきところかな https://t.co/Rk3IcAELQ5 https://t.co/7Q1jmeGYvN
https://t.co/WYGsDVLHw0 useful article on the mechanism of action and some early data for tocilizumab in COVID, which we have just started using as part of an RCT. I just need to learn how to pronounce it now
@YoshDo @NadavEyalDesk בכיוון לגמרי. אין לי כרגע תשובה מ־3 במארס בשימוש בפרוטוקול הטיפול בסין ומומלץ להפחתת תמותה המחקר הצרפתי (סמיות כפולה) נעשה על 129 חולים קשה והתוצאות חיוביות במיוחד. עוד לא פורסם אך מדובר בהפחתת תמותה ביחס לטיפול רגיל. נחקר בסין על 21
4月14日に発表されている中国での臨床結果。重篤患者に有効でサイトカインストームを抑制するようだ。 「Why tocilizumab could be an effective treatment for severe COVID-19?」 https://t.co/xskdbJThGV
うん、そういうデータが出始めましたね。
IL-6が高値のCOVID-19患者にはトシリズマブが有望だろうと。 当然と言えば当然。 Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine https://t.co/MBgHEkqPBZ
And the work continues . . .#Covid19Therapeutics https://t.co/mBHiGZu5sd
L'étude ici : https://t.co/qwyklDhVfe
Effective Treatment of Severe COVID-19 Patients with Tocilizumab https://t.co/p6NfVAotuj 同じ著者による次の論文もある。 Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Ae1Qq16tZU →続
Now study in Italy showing success.... Coronavirus a Brescia, lo studio dell’università: sul 70% dei pazienti è efficace il Tocilizumab Why #tocilizumab could be an effective treatment for severe COVID-19? https://t.co/lY04BZzKCU
#関節リウマチ の治療薬である、#トシリズマブ 。確かにそれなら、#サイトカインスキーム を抑えられると思う。 Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text https://t.co/jEwicmNlse
Core Pubmed: Why tocilizumab could be an effective treatment for severe COVID-19?: Related Articles Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020 04 14;18(1):164 Authors: Fu B,… https://t.co/nGU7KUL4Oq #coronaviru
Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/7pNrujJyLa
RT @tango_ballet: この論文も, COVID関連 CRS(サイトカイン放出症候群)への効果をかなり期待している論調. 図が綺麗なことと, IL-6阻害薬の適応/除外基準案を表としてみやすく載せているのが特徴. https://t.co/FQFRAroxNF
この論文も, COVID関連 CRS(サイトカイン放出症候群)への効果をかなり期待している論調. 図が綺麗なことと, IL-6阻害薬の適応/除外基準案を表としてみやすく載せているのが特徴. https://t.co/FQFRAroxNF
RT @CIMSFHUVH: Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm
RT @CIMSFHUVH: Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm
RT @CIMSFHUVH: Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm
RT @CIMSFHUVH: Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm
RT @CIMSFHUVH: Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm
Why tocilizumab could be an effective treatment for severe COVID-19? https://t.co/Qzi0k8F3T8 https://t.co/7WrVINADsm